After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
BTIG Reiterates Buy Rating on Hims and Hers (HIMS), PT $85
August 5, 2025 9:32 AM EDTBTIG analyst David Larsen reiterated a Buy rating and $85.00 price target on Hims and Hers (NYSE: HIMS).
The analyst comments " On Monday, AMC, HIMS reported 2Q:25 results. Revenue of $544.8M +73% y/y was behind BTIG / consensus of $560.9M / $552M though adjusted EBITDA of $82.2M was well ahead of BTIG / consensus of $80.4M / $73M. Excluding several increases in costs related to hiring new talent, EBITDA would have been closer to ~$90M. Relative to our model, the... More
William Blair Reiterates Market Perform Rating on Palantir Technologies Inc. (PLTR)
August 5, 2025 7:07 AM EDTWilliam Blair analyst Louie DiPalma reiterated a Market Perform rating on Palantir Technologies Inc. (NASDAQ: PLTR).
The analyst comments "Palantir shares are trading over 3% higher after the company reported a major revenue growth acceleration from 39% for the March quarter to 48% for the June quarter. This acceleration was especially impressive when considering Palantir was able to once again increase its margin to 46%, thereby producing a rule-of-94 quarter. Shares have increased by 91% since our March 5 upgrade to Market Perform, compared with the Nasdaq 100s... More
Palantir Technologies Inc. (PLTR) PT Raised to $200 at Wedbush
August 5, 2025 6:51 AM EDTWedbush analyst Dan Ives raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $200.00 (from $160.00) while maintaining a Outperform rating.
The analyst comments "We maintain our OUTPERFORM rating on PLTR while raising our price target from $160 to $200 reflecting continued hyper growth demand for the companys AI product suite with the use case era of the AI Revolution now here. This was another eye-popping quarter for the Messi of AI as AIP... More
Hims and Hers (HIMS) PT Raised to $43 at Leerink Partners
August 5, 2025 6:36 AM EDTLeerink Partners analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $43.00 (from $42.00) while maintaining a Market Perform rating.
The analyst comments "Bottom Line: HIMS appears to be in somewhat of a transitory stage, with the companys first revenue miss driven by both the sequential (expected) decline in GLP-1 revenue and the sequential (unexpected) decline in core revenue outside of GLP-1s. We... More
Palantir Technologies Inc. (PLTR) PT Raised to $180 at BofA Securities
August 5, 2025 6:17 AM EDTBofA Securities analyst Mariana Perez Mora raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $180.00 (from $150.00) while maintaining a Buy rating.
The analyst comments "I. J. Good speculated the first ultra-intelligent machine would lead to an intelligence explosion and mark the... More
Palantir Technologies Inc. (PLTR) PT Raised to $170 at DA Davidson
August 5, 2025 5:29 AM EDTDA Davidson analyst Gil Luria raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $170.00 (from $115.00) while maintaining a Neutral rating.
The analyst comments "Premium Valuation. We believe Palantir is the best story in all of Software. We have raised our... More
